158 related articles for article (PubMed ID: 36988820)
1. Locoregional Recurrence of Esophageal Cancer Treated with Curative Intent Local Salvage Therapy: A Single Center Experience.
Grou-Boileau F; Tankel J; Nevo Y; Najmeh S; Spicer J; Cools-Lartigue J; Mueller C; Ferri L
J Gastrointest Cancer; 2023 Dec; 54(4):1292-1299. PubMed ID: 36988820
[TBL] [Abstract][Full Text] [Related]
2. Definitive chemoradiation for locoregional recurrences of esophageal cancer after primary curative treatment.
Jeene PM; Versteijne E; van Berge Henegouwen MI; Bergmann JJ; Geijsen ED; Muller K; van Laarhoven HW; Hulshof MC
Dis Esophagus; 2017 Feb; 30(2):1-5. PubMed ID: 27766725
[TBL] [Abstract][Full Text] [Related]
3. Salvage esophagectomy for locoregional failure after chemoradiotherapy in patients with advanced esophageal cancer.
Yoo C; Park JH; Yoon DH; Park SI; Kim HR; Kim JH; Jung HY; Lee GH; Choi KD; Song HJ; Song HY; Shin JH; Cho KJ; Kim YH; Kim SB
Ann Thorac Surg; 2012 Dec; 94(6):1862-8. PubMed ID: 22959577
[TBL] [Abstract][Full Text] [Related]
4. Patterns of recurrence after surgery and efficacy of salvage therapy after recurrence in patients with thoracic esophageal squamous cell carcinoma.
Ni W; Yang J; Deng W; Xiao Z; Zhou Z; Zhang H; Chen D; Feng Q; Liang J; Lv J; Wang X; Wang X; Zhang T; Bi N; Deng L; Wang W
BMC Cancer; 2020 Feb; 20(1):144. PubMed ID: 32087687
[TBL] [Abstract][Full Text] [Related]
5. Isolated local recurrence or solitary solid organ metastasis after esophagectomy for cancer is not the end of the road.
Depypere L; Lerut T; Moons J; Coosemans W; Decker G; Van Veer H; De Leyn P; Nafteux P
Dis Esophagus; 2017 Jan; 30(1):1-8. PubMed ID: 27704661
[TBL] [Abstract][Full Text] [Related]
6. EMR as salvage treatment for patients with locoregional failure of definitive chemoradiotherapy for esophageal cancer.
Hattori S; Muto M; Ohtsu A; Boku N; Manabe T; Doi T; Ishikura S; Yoshida S
Gastrointest Endosc; 2003 Jul; 58(1):65-70. PubMed ID: 12838223
[TBL] [Abstract][Full Text] [Related]
7. Patterns of recurrent disease after neoadjuvant chemoradiotherapy and esophageal cancer surgery with curative intent in a tertiary referral center.
Schuring N; Stam WT; Plat VD; Kalff MC; Hulshof MCCM; van Laarhoven HWM; Derks S; van der Peet DL; van Berge Henegouwen MI; Daams F; Gisbertz SS
Eur J Surg Oncol; 2023 Oct; 49(10):106947. PubMed ID: 37355392
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of lymphadenectomy for lymph node recurrence after esophagectomy or definitive chemoradiotherapy for squamous cell carcinoma of the esophagus.
Watanabe M; Mine S; Yamada K; Shigaki H; Baba Y; Yoshida N; Kajiyama K; Yamamoto N; Sano T; Baba H
Gen Thorac Cardiovasc Surg; 2014 Nov; 62(11):685-92. PubMed ID: 24965711
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic results of proton beam therapy with concurrent chemotherapy for cT1 esophageal cancer and salvage endoscopic therapy for local recurrence.
Sato D; Motegi A; Kadota T; Kojima T; Bando H; Shinmura K; Hori K; Yoda Y; Oono Y; Zenda S; Ikematsu H; Akimoto T; Yano T
Esophagus; 2020 Jul; 17(3):305-311. PubMed ID: 31965362
[TBL] [Abstract][Full Text] [Related]
10. [Salvage surgery in esophageal cancer : Feasibility in patients after definitive radiochemotherapy (> 50 Gy)].
Schmidt T; Sisic L; Sterzing F; Haag GM; Kunzmann R; Grenacher L; Weichert W; Jäger D; Büchler MW; Ott K
Chirurg; 2015 Oct; 86(10):955-62. PubMed ID: 25715974
[TBL] [Abstract][Full Text] [Related]
11. En bloc esophagectomy reduces local recurrence and improves survival compared with transhiatal resection after neoadjuvant therapy for esophageal adenocarcinoma.
Rizzetto C; DeMeester SR; Hagen JA; Peyre CG; Lipham JC; DeMeester TR
J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1228-36. PubMed ID: 18544359
[TBL] [Abstract][Full Text] [Related]
12. Is pneumonectomy justifiable for patients with a locoregional recurrence or persistent disease after curative intent chemoradiotherapy for locally advanced non-small cell lung cancer?
Joosten PJM; Dickhoff C; van der Noort V; Klomp HM; van Diessen JNA; Dahele M; Bahce I; Veenhof AAFA; Smit EF; Hartemink KJ
Lung Cancer; 2020 Dec; 150():209-215. PubMed ID: 33220611
[TBL] [Abstract][Full Text] [Related]
13. Comparison of salvage chemoradiation versus salvage surgery for recurrent esophageal squamous cell carcinoma after definitive radiochemotherapy or radiotherapy alone.
Chen Y; Lu Y; Wang Y; Yang H; Xia Y; Chen M; Song H; Li T; Li D; Wang J; Li S; Wang J
Dis Esophagus; 2014; 27(2):134-40. PubMed ID: 23088212
[TBL] [Abstract][Full Text] [Related]
14. Modified En Bloc Esophagectomy Compared With Standard Resection After Neoadjuvant Chemoradiation.
Corsini EM; Mitchell KG; Zhou N; Antonoff MB; Mehran RJ; Rice DC; Roth JA; Sepesi B; Swisher SG; Vaporciyan AA; Walsh GL; Maru DM; Lin SH; Ajani JA; Hofstetter WL
Ann Thorac Surg; 2021 Apr; 111(4):1133-1140. PubMed ID: 32857997
[TBL] [Abstract][Full Text] [Related]
15. Locoregional failure rate after preoperative chemoradiation of esophageal adenocarcinoma and the outcomes of salvage strategies.
Sudo K; Taketa T; Correa AM; Campagna MC; Wadhwa R; Blum MA; Komaki R; Lee JH; Bhutani MS; Weston B; Skinner HD; Maru DM; Rice DC; Swisher SG; Hofstetter WL; Ajani JA
J Clin Oncol; 2013 Dec; 31(34):4306-10. PubMed ID: 24145339
[TBL] [Abstract][Full Text] [Related]
16. Salvage chemoradiation therapy for recurrence after radical surgery or palliative surgery in esophageal cancer patients: a prospective, multicenter clinical trial protocol.
Chang X; Deng L; Ni W; Li C; Han W; Gao LR; Wang S; Zhou Z; Chen D; Feng Q; Liang J; Bi N; Lv J; Gao S; Mao Y; Xue Q; Xiao Z
BMC Cancer; 2020 Sep; 20(1):877. PubMed ID: 32928136
[TBL] [Abstract][Full Text] [Related]
17. A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma.
Ni W; Yu S; Zhang W; Xiao Z; Zhou Z; Chen D; Feng Q; Liang J; Lv J; Gao S; Mao Y; Xue Q; Sun K; Liu X; Fang D; Li J; Wang D
BMC Cancer; 2020 Feb; 20(1):130. PubMed ID: 32070309
[TBL] [Abstract][Full Text] [Related]
18. Patterns of recurrence following definitive chemoradiation for patients with proximal esophageal cancer.
de Vos-Geelen J; Geurts SME; Nieuwenhuijzen GAP; Voncken FEM; Bogers JA; Braam PM; Muijs CT; de Jong MA; Kasperts N; Rozema T; Blom GJ; Bouwense SAW; Valkenburg-van Iersel LBJ; Jeene PM; Hoebers FJP; Tjan-Heijnen VCG
Eur J Surg Oncol; 2021 Aug; 47(8):2016-2022. PubMed ID: 33583629
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of endoscopic mucosal resection as salvage treatment for patients with local failure after definitive chemoradiotherapy for stage IB, II, and III esophageal squamous cell cancer.
Makazu M; Kato K; Takisawa H; Yoshinaga S; Oda I; Saito Y; Mayahara H; Ito Y; Itami J; Hamaguchi T; Yamada Y; Shimada Y
Dis Esophagus; 2014 Jan; 27(1):42-9. PubMed ID: 23442160
[TBL] [Abstract][Full Text] [Related]
20. Salvage endoscopic resection (ER) after chemoradiotherapy for esophageal squamous cell carcinoma: What are the risk factors for recurrence after salvage ER?
Hombu T; Yano T; Hatogai K; Kojima T; Kadota T; Onozawa M; Yoda Y; Hori K; Oono Y; Ikematsu H; Fujii S
Dig Endosc; 2018 May; 30(3):338-346. PubMed ID: 29106753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]